ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "How can India’s pharma companies survive under Trump’s uncertainty?"
Episode Synopsis
In today’s episode on 21st July 2025, we follow a $2 billion cancer-drug deal, review India’s decades-old drug-manufacturing playbook, and ask whether an “America-first” clampdown could force domestic drugmakers to climb the value ladder faster than ever.
More episodes of the podcast Finshots Daily
The ₹150-crore prop-trading scam
15/11/2025
What SEBI’s new AIF rules mean
13/11/2025
India wants its own stablecoin?
12/11/2025
The PhysicsWallah IPO explained
12/11/2025
The Tata Trusts saga explained
10/11/2025
What happened to all the T+0 excitement?
07/11/2025
A breakthrough that might break the internet
06/11/2025
The Groww IPO explained
04/11/2025
In God we trust